Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1249INDUSTRY 849NIH 53OTHER_GOV 33NETWORK 32UNKNOWN 3FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Prostatic Neoplasms 46Neoplasms 36Colorectal Neoplasms 36Lung Neoplasms 21Breast Neoplasms 13Colonic Polyps 11Colonic Neoplasms 11Rare Diseases 9Carcinoma, Non-Small-Cell Lung 9Carcinoma, Hepatocellular 7Pulmonary Disease, Chronic Obstructive 6Neoplasm Metastasis 6Heart Failure 6Ovarian Neoplasms 5Motor Activity 5Liver Neoplasms 5Head and Neck Neoplasms 5Fibrosis 5Carcinoma, Squamous Cell 5Barrett Esophagus 5Adenoma 5Urinary Bladder Neoplasms 4Neoplasms by Site 4Mental Disorders 4Lymphoma 4Lung Diseases 4Leukemia 4Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Urinary Incontinence 3

Interventions

Oxaliplatin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
FED × Interventional × Recurrence × Clear all
NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Minneapolis Veterans Affairs Medical Center

Phase 2 Terminated
35 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00018538 2009-01-21

Calcifidol Therapy in Men With Cancer

VA Office of Research and Development

Phase 2 Completed
Genitourinary

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡